Evidence map›Paper›PMID 39015336›Full record

ArticleFrontiers in cellular and infection microbiology2024

Emergence of a clinical

Long He, Wenji Wang, Liman Ma, Dongguo Wang, Shanshan Long

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Long He *Department of Clinical Laboratory Medicine, Wenling First People's Hospital, Taizhou, Zhejiang, China.
Wenji Wang *School of Life Sciences, Taizhou University, Taizhou, Zhejiang, China.
Liman MaSchool of Medicine, Taizhou University, Taizhou, Zhejiang, China.
Dongguo Wang *Department of Central Laboratory, Taizhou Municipal Hospital affiliated with Taizhou University, Taizhou, Zhejiang, China.
Shanshan LongDepartment of Laboratory Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The emergence of clinical Methods: In order to study the detailed genetic features of Results: Conclusion: The structure of the SC35 plasmid p1 appears to have evolved in correlation with other plasmids such as pKPC2_130119, pDD01754-2, and F4_plasmid pA. The infectious strain SC35 exhibits no susceptibility to tested antibioticst, thus effective measures should be taken to prevent the spread and epidemic of this strain.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesChromosomes, BacterialKlebsiella InfectionsKlebsiella pneumoniaePlasmidsBacterial ProteinsHumansInterspersed Repetitive SequencesMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase KPC-2, Klebsiella pneumoniaebeta-LactamasesacrAB-tolCK. pneumoniaeSC35 chromosomeSC35 plasmid p1the two repetitive tandem core structures for blaKPC-2 and blaCTX-M-65

Identifiers

PMID39015336
PMCPMC11250256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.